Global public health and safety organization NSF announced its acquisition of Cambium Analytica, an analytical testing and development company serving the natural food, beverage, and dietary supplement industries.

With the addition of Cambium Analytica, NSF said it’s now positioned to more fully meet accelerating demands, providing clients with access to integrated, best-in-class solutions at scale. This enables companies to grow demand for natural food, beverage, and supplement products while ensuring safety and quality, particularly in those seeking to innovate in these industries.

“By integrating Cambium Analytica’s cutting-edge operations with NSF’s eight decades of leadership in safety and testing, we continue to strengthen our position as the partner of choice for clients across the food and nutrition industries,” said Pedro Sancha, president and CEO, NSF. “Together, we anticipate accelerated growth, expanded capabilities, and the addition of exceptional talent to our team.”

Operating as a part of NSF’s largest division, Food and Nutrition, led by Sarah Krol, vice president, food and nutrition, NSF, the addition of Cambium Analytica’s capabilities to NSF’s business allows the organization to stay ahead of market trends and client needs, offering experts in an evolving regulatory environment.

“Cambium Analytica stands out for its unwavering commitment to agility, innovation, and a deep understanding of the specific needs of natural product brands,” said Krol. “These qualities distinguish them in the marketplace and make them an ideal fit for our food and nutrition service portfolio.”

Acquisitions have been named a commercial focus for NSF, and the organization said it is committed to growth, doubling down on global expansion, streamlining operations, and building a “groundbreaking innovation machine” to stay ahead of market demands.

“This partnership represents the perfect alignment of Cambium Analytica’s innovative, customer-centric approach with NSF’s long-established excellence in public health and safety,” said Alex Adams, CEO of Cambium Analytica. “Together, we’re positioned to lead the next wave of growth in the rapidly evolving consumer products industry — uniting disruptive agility and deep scientific expertise to create an innovative, new testing and inspection ecosystem.”

The acquisition bridges gaps in the natural products market, the companies said. Cambium’s in-process QA and batch release testing, contract research, and product development services will integrate with NSF’s audit-focused certification programs, offering clients complete support from concept through market compliance.

At this time, Cambium Analytica will be renamed Cambium Analytica, an NSF company, and its 69 employees will continue to operate out of its Traverse City, MI, headquarters.